Screener
Disc Medicine IRON Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $45.9M+65.3% | $46.22M+86.4% | $50.33M+104% | $46.32M+97.2% | $27.76M+17.1% | ||
| $23.62M+93.9% | $20.75M+113% | $17.36M+112% | $15.09M+105% | $12.18M+57.0% | ||
| $69.52M+74.0% | $66.97M+93.8% | $67.7M+106% | $61.41M+99.0% | $39.95M+27.0% | ||
| $844K-5.9% | $883K+54.4% | $917K— | $910K— | $897K— | ||
| $6.07M+1.5% | $6.53M+23.9% | $5.48M-14.0% | $6.22M+36.3% | $5.98M+32.4% | ||
| $51K-57.1% | $88K-50.0% | $102K-10.5% | $52K-13.3% | $119K+2,280% | ||
| -$63.5M-86.3% | -$60.53M-105% | -$62.32M-134% | -$55.25M-110% | -$34.09M-26.5% | ||
| -$1.65-61.8% | -$1.62-65.3% | -$1.77-98.9% | -$1.58-53.4% | -$1.02+6.4% | ||
| -$69.44M-73.9% | -$66.88M-93.6% | -$67.61M-106% | -$61.33M-99.5% | -$39.93M-27.0% | ||
| -$69.52M-74.0% | -$66.97M-93.8% | -$67.7M-106% | -$61.41M-99.0% | -$39.95M-27.0% |
FAQ
- Is Disc Medicine profitable?
- Disc Medicine is not currently profitable: it reported a net loss of $241.6M over the trailing twelve months.
- What is Disc Medicine's earnings per share?
- Disc Medicine's diluted EPS over the trailing twelve months is $-6.62.
- Where does Disc Medicine's income statement data come from?
- Every line is extracted from Disc Medicine's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.